FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2954962009> ?p ?o ?g. }

• W2954962009 endingPage "18770" @default.
• W2954962009 startingPage "18762" @default.
• W2954962009 abstract "In human, there are two myxovirus resistance genes-MX1 and MX2, which respectively encode MXA and MXB protein. For MXB, it was traditionally deemed to work in the progression of cell cycle and adjustment of nuclear import. Thus, we speculated that it might play important roles in tumor progression. The purpose of this study was to preliminarily explore the underlying functions and mechanism of the MX2 gene on glioblastoma multiforme. Quantitative reverse transcription polymerase chain reaction, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT), and transwell experiments were to detect the relative MX2 mRNA level and its biological functions on glioma cells, respectively. The data displayed that MX2 was obviously downregulated both in glioblastoma (GBM) and GBM cell lines, meanwhile, its overexpression could markedly reduce cell proliferation, migration, and invasion of glioma cells, implying that it was related with glioblastoma progression. In addition, the overall survival of patient with glioblastoma had a negative correlation with the MX2 expression. Then, Western blot indicated the potential mechanism of MX2 in glioblastoma. We found that MX2 overexpression could decrease the relative levels of phosphorylated-ERK1/2 (p-ERK1/2), p-p38, and nuclear factor-κB (NF-κB), while have no effects on extracellular signal-regulated kinase (ERK), p38, and lamin B1. Moreover, the influences of MX2 overexpression on cell proliferation, migration, and invasion could be weakened by the three inhibitors (PD98059, SB203580, and (pyridin-2-ylmethyl) dithiocarbamate [PDTC]). These results implied that MX2 might suppress the proliferation and metastasis of glioma cells by manipulating the ERK/P38/NF-κB signaling pathway. In conclusion, MX2 is potential to be a new marker used for glioblastoma prognosis or a new target for glioblastoma treatments." @default.
• W2954962009 created "2019-07-12" @default.
• W2954962009 creator A5013131668 @default.
• W2954962009 creator A5016473420 @default.
• W2954962009 creator A5019887317 @default.
• W2954962009 creator A5046230243 @default.
• W2954962009 creator A5047230992 @default.
• W2954962009 date "2019-07-02" @default.
• W2954962009 modified "2023-10-17" @default.
• W2954962009 title "Overexpression of human MX2 gene suppresses cell proliferation, migration, and invasion via ERK/P38/NF‐κB pathway in glioblastoma cells" @default.
• W2954962009 cites W1546884011 @default.
• W2954962009 cites W1552626038 @default.
• W2954962009 cites W1805954825 @default.
• W2954962009 cites W1975061879 @default.
• W2954962009 cites W1986829091 @default.
• W2954962009 cites W2003793026 @default.
• W2954962009 cites W2027680432 @default.
• W2954962009 cites W2029316768 @default.
• W2954962009 cites W2030277568 @default.
• W2954962009 cites W2033162292 @default.
• W2954962009 cites W2039325208 @default.
• W2954962009 cites W2043726848 @default.
• W2954962009 cites W2048756523 @default.
• W2954962009 cites W2056753605 @default.
• W2954962009 cites W2081563673 @default.
• W2954962009 cites W2084470850 @default.
• W2954962009 cites W2093904762 @default.
• W2954962009 cites W2101505589 @default.
• W2954962009 cites W2101995865 @default.
• W2954962009 cites W2114174430 @default.
• W2954962009 cites W2151335185 @default.
• W2954962009 cites W2153558039 @default.
• W2954962009 cites W2158681922 @default.
• W2954962009 cites W2158734599 @default.
• W2954962009 cites W2160382843 @default.
• W2954962009 cites W2163409417 @default.
• W2954962009 cites W2272984102 @default.
• W2954962009 cites W2613072848 @default.
• W2954962009 cites W2793506647 @default.
• W2954962009 cites W2803453391 @default.
• W2954962009 cites W2820668537 @default.
• W2954962009 cites W2884584240 @default.
• W2954962009 cites W2886743862 @default.
• W2954962009 doi "https://doi.org/10.1002/jcb.29189" @default.
• W2954962009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31265172" @default.
• W2954962009 hasPublicationYear "2019" @default.
• W2954962009 type Work @default.
• W2954962009 sameAs 2954962009 @default.
• W2954962009 citedByCount "15" @default.
• W2954962009 countsByYear W29549620092019 @default.
• W2954962009 countsByYear W29549620092020 @default.
• W2954962009 countsByYear W29549620092021 @default.
• W2954962009 countsByYear W29549620092022 @default.
• W2954962009 countsByYear W29549620092023 @default.
• W2954962009 crossrefType "journal-article" @default.
• W2954962009 hasAuthorship W2954962009A5013131668 @default.
• W2954962009 hasAuthorship W2954962009A5016473420 @default.
• W2954962009 hasAuthorship W2954962009A5019887317 @default.
• W2954962009 hasAuthorship W2954962009A5046230243 @default.
• W2954962009 hasAuthorship W2954962009A5047230992 @default.
• W2954962009 hasConcept C128473837 @default.
• W2954962009 hasConcept C1491633281 @default.
• W2954962009 hasConcept C153911025 @default.
• W2954962009 hasConcept C184235292 @default.
• W2954962009 hasConcept C2778227246 @default.
• W2954962009 hasConcept C29537977 @default.
• W2954962009 hasConcept C502942594 @default.
• W2954962009 hasConcept C51551487 @default.
• W2954962009 hasConcept C54355233 @default.
• W2954962009 hasConcept C57074206 @default.
• W2954962009 hasConcept C62112901 @default.
• W2954962009 hasConcept C81885089 @default.
• W2954962009 hasConcept C86803240 @default.
• W2954962009 hasConcept C95444343 @default.
• W2954962009 hasConceptScore W2954962009C128473837 @default.
• W2954962009 hasConceptScore W2954962009C1491633281 @default.
• W2954962009 hasConceptScore W2954962009C153911025 @default.
• W2954962009 hasConceptScore W2954962009C184235292 @default.
• W2954962009 hasConceptScore W2954962009C2778227246 @default.
• W2954962009 hasConceptScore W2954962009C29537977 @default.
• W2954962009 hasConceptScore W2954962009C502942594 @default.
• W2954962009 hasConceptScore W2954962009C51551487 @default.
• W2954962009 hasConceptScore W2954962009C54355233 @default.
• W2954962009 hasConceptScore W2954962009C57074206 @default.
• W2954962009 hasConceptScore W2954962009C62112901 @default.
• W2954962009 hasConceptScore W2954962009C81885089 @default.
• W2954962009 hasConceptScore W2954962009C86803240 @default.
• W2954962009 hasConceptScore W2954962009C95444343 @default.
• W2954962009 hasIssue "11" @default.
• W2954962009 hasLocation W29549620091 @default.
• W2954962009 hasLocation W29549620092 @default.
• W2954962009 hasOpenAccess W2954962009 @default.
• W2954962009 hasPrimaryLocation W29549620091 @default.
• W2954962009 hasRelatedWork W1547736903 @default.
• W2954962009 hasRelatedWork W2066519212 @default.
• W2954962009 hasRelatedWork W2072481810 @default.
• W2954962009 hasRelatedWork W2306091558 @default.
• W2954962009 hasRelatedWork W2361547949 @default.

• next